Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05977621 · ClinicalTrials.gov registry record
Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking
A clinical trial of Uterine Cancer, sponsored by Duke University.
- Recruiting
- Registry status
- 17
- Enrollment target
- 1
- Study location
NCT05977621 is a study of Uterine Cancer that is actively recruiting participants, run by Duke University. The registered enrollment target is 17 participants, below the 271-participant average among 27 other Uterine Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05977621, a study of Uterine Cancer, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to utilize transrectal ultrasound (TRUS) images of the intact and post-hysterectomy female pelvis in order to provide feasibility information for a Magnetic Resonance Imaging (MRI)-TRUS fusion based 3D needle navigation system for use in image guided brachytherapy. The fusion and needle guidance will be performed using Eigen Health's navigation system that currently provides targeted MR/Ultrasound fusion based prostate biopsies utilizing a proprietary 3D semi-robotic navigation system.
Conditions Studied
Interventions
- OTHER Transrectal ultrasound (TRUS)
Study Locations (1)
North Carolina
- Duke Cancer Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2024-02-07 |
| Est. Completion | 2027-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05977621
The ClinicalTrials.gov registry entry for NCT05977621 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 271-participant average among 27 other Uterine Cancer trials with a reported enrollment target (94% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Uterine Cancer appearing as the primary indexed condition, and to 1 intervention - of which Transrectal ultrasound (TRUS) is the first listed.
NCT05977621 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05977621 about?
NCT05977621 is a clinical study titled "Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking". The purpose of this study is to utilize transrectal ultrasound (TRUS) images of the intact and post-hysterectomy female pelvis in order to provide feasibility information for a Magnetic Resonance Imaging (MRI)-TRUS fusion based 3D needle navigation system for use in image guided brachytherapy. The f...
What is the current status of trial NCT05977621?
This trial is currently recruiting. The enrollment target is 17 participants. The study started on 2024-02-07. Estimated completion is 2027-03.
What conditions does trial NCT05977621 study?
This clinical trial studies the following conditions: Uterine Cancer.
What interventions are being tested in trial NCT05977621?
The interventions under investigation include: Transrectal ultrasound (TRUS) (OTHER).
Who is sponsoring clinical trial NCT05977621?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05977621 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Azenosertib in Uterine Serous Carcinoma: Biomarker Study
RECRUITING · Phase 2
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
-
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
RECRUITING · Phase 1
-
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
RECRUITING · Phase 1
-
PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
RECRUITING · Phase 2
-
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.